“FMBA of Russia is also conducting scientific research to develop technology for the production of a drug substance for the treatment of several diseases caused by poxviruses, including monkeypox,” TASS said in a statement.
The agency added that the creation of technology will help, if necessary, to expand the production of a drug for the treatment of a dangerous infectious disease in the shortest possible time.
Earlier, Alexander Gorelov, deputy director of the Central Research Institute of Epidemiology of Rospotrebnadzor, said that a Russian who fell ill with monkeypox had passed the incubation period.